Mortality After Hip and Spine Fractures in Patients With End-Stage Kidney Disease: A Systematic Review and Meta-Analysis

医学 荟萃分析 死亡率 腹膜透析 肾脏疾病 髋部骨折 透析 肾脏替代疗法 血液透析 队列研究 死亡风险 外科 内科学 骨质疏松症
作者
Yoshinosuke Shimamura,Yasutaka Kuniyoshi,Hiroshi Ueta,Takamasa Miyauchi,Mari Yamamoto,Yasushi Tsujimoto
出处
期刊:Cureus [Cureus, Inc.]
被引量:1
标识
DOI:10.7759/cureus.49636
摘要

Fractures represent a major cause of disability in the elderly, and patients with fractures exhibit a higher mortality rate than those without. Fractures are also an important health problem among patients with end-stage kidney disease (ESKD) requiring hemodialysis, peritoneal dialysis, or kidney transplantation. To the best of our knowledge, no study in the literature has yet quantitatively summarized the mortality rates, and a summary of evidence on post-hip and spine fracture mortality in patients with ESKD is lacking. The purpose of this study is to quantitatively evaluate the mortality rate, one-year mortality rate, and five-year mortality rate after hip and spine fractures in patients with ESKD receiving kidney replacement therapy. The MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and ClinicalTrials.gov databases were comprehensively searched for reports on mortality rate and time-period mortality in patients with ESKD after hip or spine fractures up to June 2022. Prospective and retrospective cohort studies, as well as case series involving four or more patients, were included. Pooled mortality rate, one-year rate, and five-year mortality rate with 95% confidence intervals (CIs) were examined using a random-effects model. The risk of bias was assessed using the Joanna Briggs Institute (JBI) Prevalence Critical Appraisal Tool. Additionally, heterogeneity between studies was evaluated. A total of 26 studies were included in this meta-analysis. The one-year and five-year mortality rates after hip and spine fractures were 215.35-774.0 per 1,000 person-year and 148-194.1 per 1,000 person-year, respectively. After hip fractures, the one-year mortality rate was 27% (95% CI: 18-38%, I2 = 98%), whereas the five-year mortality rate was 56% (95% CI: 41-71%, I2 = 99%). After spine fractures, the one-year mortality rate was 10% (95% CI: 4-17%, I2 = 70%), whereas the five-year mortality rate was 48.3%. The post-fracture mortality rate was high in patients with ESKD, particularly within one year after the occurrence of fractures. Additionally, the five-year mortality rate after hip femoral or spine fractures was high at approximately 50%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
minhuangincn完成签到,获得积分10
4秒前
花花猪1989完成签到,获得积分10
6秒前
6秒前
hkh发布了新的文献求助10
6秒前
Orange应助雪白的雪采纳,获得30
6秒前
傅筮完成签到 ,获得积分10
7秒前
zyxxxx完成签到 ,获得积分10
9秒前
胖胖的伏特加完成签到,获得积分10
11秒前
12秒前
15秒前
minforphd完成签到,获得积分10
17秒前
Uncle发布了新的文献求助10
17秒前
新手小白关注了科研通微信公众号
19秒前
DICPGLF完成签到 ,获得积分10
19秒前
20秒前
脑洞疼应助动听安筠采纳,获得20
20秒前
鲤鱼凛发布了新的文献求助10
23秒前
是YN呀完成签到 ,获得积分10
25秒前
Magic完成签到,获得积分10
26秒前
zhao发布了新的文献求助10
26秒前
Uncle完成签到,获得积分10
27秒前
小吴同学来啦完成签到,获得积分10
28秒前
ZSQ完成签到,获得积分10
28秒前
研友_LwbeX8完成签到,获得积分0
28秒前
志存高远完成签到,获得积分10
29秒前
cfy完成签到,获得积分10
30秒前
今天要努力啊完成签到,获得积分10
30秒前
你一头牛牛牛牛完成签到,获得积分10
31秒前
充电宝应助Uncle采纳,获得10
31秒前
ding应助fangzhang采纳,获得10
31秒前
小爽完成签到,获得积分10
31秒前
32秒前
清爽的诗槐完成签到,获得积分10
33秒前
34秒前
36秒前
雪白的雪发布了新的文献求助30
38秒前
40秒前
七少爷完成签到 ,获得积分10
40秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
A radiographic standard of reference for the growing knee 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2469202
求助须知:如何正确求助?哪些是违规求助? 2136414
关于积分的说明 5443405
捐赠科研通 1860897
什么是DOI,文献DOI怎么找? 925519
版权声明 562701
科研通“疑难数据库(出版商)”最低求助积分说明 495140